Breaking News: Embargoed Feed - hidden

Filters close
Newswise: Mount Sinai Study Identifies Genetic Link Between Inflammatory Bowel Disease and Parkinson’s Disease
13-May-2024 12:05 PM EDT
Mount Sinai Study Identifies Genetic Link Between Inflammatory Bowel Disease and Parkinson’s Disease
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery, identifying genetic connections between inflammatory bowel disease (IBD) and Parkinson’s disease (PD). Published in Genome Medicine on May 13, their study highlights the potential for joint therapeutic strategies to target these two challenging disorders.

Query Closed
Reporter's Deadline Passed
10-May-2024 9:15 AM EDT
How often do bed pillows - Amelia Jerden, The Strategist / New York Magazine
Newswise Expert Queries

How often do bed pillows need to be replaced? The common rule of thumb appears

   
Newswise: Catch and Release Can Give Sea Turtles the Bends #ASA186
6-May-2024 2:05 PM EDT
Catch and Release Can Give Sea Turtles the Bends #ASA186
Acoustical Society of America (ASA)

Fishers are typically unaware if a sea turtle is caught in their net until it’s completely pulled out of the water. However, releasing sea turtles without veterinary evaluations can be harmful.

Not for public release

This news release is embargoed until 13-May-2024 4:00 PM EDT Released to reporters: 7-May-2024 1:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 16-May-2024 5:00 PM EDT Released to reporters: 13-May-2024 3:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 15-May-2024 4:00 PM EDT Released to reporters: 13-May-2024 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-May-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 22-May-2024 2:00 PM EDT Released to reporters: 13-May-2024 12:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-May-2024 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 17-May-2024 2:00 PM EDT Released to reporters: 13-May-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-May-2024 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 21-May-2024 2:15 PM EDT Released to reporters: 13-May-2024 9:40 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-May-2024 2:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 21-May-2024 2:15 PM EDT Released to reporters: 13-May-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-May-2024 2:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 21-May-2024 12:40 PM EDT Released to reporters: 13-May-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-May-2024 12:40 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 20-May-2024 1:15 PM EDT Released to reporters: 13-May-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2024 1:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

9-May-2024 11:05 AM EDT
Getting out of the political echo chamber
American Psychological Association (APA)

Civilized political debates may seem increasingly out of reach as democracies across the world face rising polarization, but people still want to discuss issues with people they disagree with – especially those who present themselves as balanced and willing to seek solutions that work for everyone or open to learning new information, according to two studies published by the American Psychological Association.

Newswise: Intense Ultrasound Extracts Genetic Info for Less Invasive Cancer Biopsies #ASA186
6-May-2024 8:05 AM EDT
Intense Ultrasound Extracts Genetic Info for Less Invasive Cancer Biopsies #ASA186
Acoustical Society of America (ASA)

At the University of Alberta, researchers explored how intense ultrasound can release biological indicators of disease from cells. These biomarkers can help identify different types of cancer and inform the subsequent therapy.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 14-May-2024 11:00 AM EDT Released to reporters: 13-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-May-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 19-May-2024 5:15 PM EDT Released to reporters: 13-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2024 5:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 19-May-2024 12:15 PM EDT Released to reporters: 13-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2024 12:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 19-May-2024 5:15 PM EDT Released to reporters: 13-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2024 5:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 20-May-2024 12:15 PM EDT Released to reporters: 13-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2024 12:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 19-May-2024 5:15 PM EDT Released to reporters: 13-May-2024 8:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2024 5:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   

Not for public release

This news release is embargoed until 19-May-2024 5:40 PM EDT Released to reporters: 13-May-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2024 5:40 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: LLNL debuts trio of systems on new Top500 list of world’s most powerful supercomputers, including El Capitan Early Delivery System
10-May-2024 4:05 PM EDT
LLNL debuts trio of systems on new Top500 list of world’s most powerful supercomputers, including El Capitan Early Delivery System
Lawrence Livermore National Laboratory

Three new systems currently or soon-to-be sited at Lawrence Livermore National Laboratory (LLNL) on Monday debuted on the latest Top500 list of most powerful supercomputers in the world, including the first portion of the exascale machine El Capitan.

Not for public release

This news release is embargoed until 13-May-2024 5:00 AM EDT Released to reporters: 10-May-2024 1:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

8-May-2024 6:05 AM EDT
World-first regulations to combat sedentary behaviour among children in China show global promise
University of Bristol

Pioneering measures to tackle sedentary behaviour among children in China have proved effective, according to new research.

access_time Left Before Reporter's Deadline
Reporter's Deadline: 31-May-2024 7:00 PM EDT
12-May-2024 3:03 PM EDT
We are looking for news - Lubomir Straka, Editor in Chief - www.Techpedia.sk

We are looking for news about all kinds of technologies, about research and development in

       
Newswise: 2024 Surinderjit Singh Young Lectureship Award Winner
10-May-2024 10:05 AM EDT
2024 Surinderjit Singh Young Lectureship Award Winner
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) is excited to announce Marcos V. Oliveira Marques, MD, as the 2024 Surinderjit Singh Young Lectureship Award recipient.

   
Query Closed
Reporter's Deadline Passed
9-May-2024 10:17 AM EDT
I'm doing a feature - Dinsa Sachan, Chemistry World
Newswise Expert Queries

I'm doing a feature piece on science communication officers that looks at their role

Newswise: Worker rights are one of the least protected human rights, new research reveals
1-May-2024 9:10 AM EDT
Worker rights are one of the least protected human rights, new research reveals
Binghamton University, State University of New York

Worker rights are among the least protected human rights in the world, according to new research from faculty at Binghamton University, State University of New York.

access_time Left Before Reporter's Deadline
Reporter's Deadline: 14-May-2024 7:00 PM EDT
10-May-2024 7:53 AM EDT
I run a quarterly digital - Madeleine Hall,

I run a quarterly digital publication on all things innovation. In our upcoming edition, due

Newswise: Metabolism of Autism Reveals Developmental Origins
8-May-2024 5:05 PM EDT
Metabolism of Autism Reveals Developmental Origins
University of California San Diego

New insights into the metabolism of autism from researchers at UC San Diego could help inform early detection and prevention strategies for the disorder.

Query Closed
Reporter's Deadline Passed
6-May-2024 5:03 AM EDT
I will like to have - Kehinde Akinseinde-Jayeoba, African Newspaper of Nigeria Plc
Newswise Expert Queries

I will like to have an in-depth expert analysis on the recapitalisation drive of

Query Closed
Reporter's Deadline Passed
3-May-2024 10:45 AM EDT
- Neil A Osterweil, MDedge/Medscape
Newswise Expert Queries

I'm writing a piece for MDedge Oncology

access_time Embargo lifts in 2 days
This news release is embargoed until 17-May-2024 8:35 AM EDT Released to reporters: 9-May-2024 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-May-2024 8:35 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 16-May-2024 8:25 AM EDT Released to reporters: 9-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2024 8:25 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

8-May-2024 5:05 PM EDT
Study Shows Ineffectiveness of Targeted Credit Rationing in Banking
University of Maryland, Robert H. Smith School of Business

With the recent ESG-inspired shift towards and away from the rationing of capital to specific firms that arguably generate negative externalities, a new study shows targeted credit rationing in recent history has been widely ineffective in promoting change.

access_time Embargo lifts in 2 days
This news release is embargoed until 16-May-2024 1:20 PM EDT Released to reporters: 9-May-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2024 1:20 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Query Closed
Reporter's Deadline Passed
7-May-2024 12:00 PM EDT
Right now, I’m researching - Dinsa Sachan, Chemistry World
Newswise Expert Queries

Right now, I’m researching a story on science communications officers for Chemistry World. The

3-May-2024 3:05 PM EDT
Study: Neuropathy Very Common, Underdiagnosed
American Academy of Neurology (AAN)

Neuropathy, the nerve damage that causes pain and numbness in the feet and hands and can eventually lead to falls, infection and even amputation, is very common and underdiagnosed, according to a study published in the May 8, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: Strengthening CAR-T Therapy to Work Against Solid Tumors
7-May-2024 10:00 AM EDT
Strengthening CAR-T Therapy to Work Against Solid Tumors
Montefiore Einstein Cancer Center

Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors—an advance that could transform cancer treatment. The promising findings, reported today in Science Advances, involve CAR-T cell therapy, which supercharges the immune system to identify and attack cancer cells.

access_time Embargo lifts in 2 days
This news release is embargoed until 16-May-2024 10:35 AM EDT Released to reporters: 8-May-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2024 10:35 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Mount Sinai Scientists Unravel How Psychedelic Drugs Interact with Serotonin Receptors to Potentially Produce Therapeutic Benefits
7-May-2024 3:05 PM EDT
Mount Sinai Scientists Unravel How Psychedelic Drugs Interact with Serotonin Receptors to Potentially Produce Therapeutic Benefits
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatric disorders such as depression and anxiety.

Newswise: GUIDE team develops computational approach to redesign antibodies for broader effectiveness against viral pandemics
7-May-2024 6:05 PM EDT
GUIDE team develops computational approach to redesign antibodies for broader effectiveness against viral pandemics
Lawrence Livermore National Laboratory

In a groundbreaking development for addressing future viral pandemics, a multi-institutional team involving Lawrence Livermore National Laboratory researchers has successfully combined an artificial intelligence-backed platform with supercomputing to redesign and restore the effectiveness of antibodies whose ability to fight viruses has been compromised by viral evolution. The work was published in the journal Nature.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 15-May-2024 10:30 AM EDT Released to reporters: 8-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-May-2024 10:30 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Honoring Oncology Nurses at the State’s Only NCI-designated Comprehensive Cancer Center
7-May-2024 2:05 PM EDT
Honoring Oncology Nurses at the State’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute

Three nurses have been named recipients of Rutgers Cancer Institute’s ‘Oncology Nursing Excellence Awards’ during Nurses Week this year. This year’s award recipients were named during the annual Elizabeth Gibby Osborne Lecture.

Newswise:Video Embedded swarms-of-miniature-robots-clean-up-microplastics-and-microbes-simultaneously-video
VIDEO
3-May-2024 8:00 AM EDT
Swarms of miniature robots clean up microplastics and microbes, simultaneously (video)
American Chemical Society (ACS)

In a study in ACS Nano, researchers describe swarms of microscale robots (microrobots) that captured bits of plastic and bacteria from water. Afterward, the bots were decontaminated and reused.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 16-May-2024 11:10 AM EDT Released to reporters: 8-May-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2024 11:10 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: ‘Mathematical microscope’ reveals novel, energy-efficient mechanism of working memory that works even during sleep
6-May-2024 5:05 PM EDT
‘Mathematical microscope’ reveals novel, energy-efficient mechanism of working memory that works even during sleep
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health researchers have discovered a mechanism that creates memories while reducing metabolic cost, even during sleep. This efficient memory occurs in a part of the brain that is crucial for learning and memory, and where Alzheimer’s disease begins.

7-May-2024 5:05 AM EDT
Unlocking insights into insomnia
University of Bristol

GP data can provide unique insights into common health conditions, new research looking at insomnia symptom prevalence in England has shown. The University of Bristol-led study, published in BMJ Open today [8 May], also highlights the value of improving access to this data for future health research.

Query Closed
Reporter's Deadline Passed
2-May-2024 5:36 PM EDT
Sickle cell therapies, access, history — - Maryn McKenna, Scientific American
Newswise Expert Queries

Sickle cell therapies, access, history — For a piece pegged to the approval of gene therapies

   
access_time Embargo lifts in 2 days
This news release is embargoed until 14-May-2024 3:00 PM EDT Released to reporters: 7-May-2024 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-May-2024 3:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   


close
8.41456